NYSE:ORCL

Oracle (ORCL)

156.32
-8.84 (5.35%)
as of Jun 24, 2026, 7:10:12 pm Market Open.
301 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 43 opinions in the last 12 months.

Oracle (ORCL) is currently facing mixed sentiments among experts following a series of challenges related to its massive investments in AI and data center expansions. While the company has delivered solid earnings, beating estimates with recent reports of $2.11 EPS and $19.18 billion in revenue, concerns regarding its high debt levels and reliance on OpenAI for growth persist. The stock has seen volatile price movements, heavily influenced by broader market sentiments towards tech and AI. Some experts highlight the potential for upside if Oracle's AI strategy pays off, but others caution that significant risks may lead to further downside. Overall, analysts are watching the company's upcoming earnings and capital expenditures closely, looking for clearer guidance on future growth and demand for its data centers.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
MSFT
BUY
Had a good quarter. Business spending is picking up for them.
DON'T BUY
Has dropped and recovered a bit. Could drop again. Not a fan of techs at this time.
WEAK BUY
Ranks in the top quarter of their model. Has had a "suspect" rally. Not cheap. Treat as a trading stock.
BUY
Good price.
PAST TOP PICK
(Was a top pick on May 9. Up 7%.) Still likes. Treat as a long term play.
DON'T BUY
Ranks in the middle of the pack of their database. The price to sales ratio is not cheap.
DON'T BUY
Good company. Model price is $10. Balance sheet hasn't grown.
BUY
Buy a little at a time.
WEAK BUY
Overowned in the past. Could have a rally, so treat as a trading stock.
DON'T BUY
Too many sellers on any uptick. Overowned in good times, so investors are moving their money.
DON'T BUY
Needs to be successful on its applications side of the business. Database side is OK, but not growing.
TOP PICK
16 X next years earnings.
DON'T BUY
Have to wait for corporate spending to increase.
DON'T BUY
7 X sales. Strong competition. Might buy at $8.
BUY
Can see it appreciating.
Showing 301 to 315 of 374 entries